Results 251 to 260 of about 38,942 (318)

Therapeutic outcomes of ranibizumab for zone ii stage 2 retinopathy of prematurity with plus disease. [PDF]

Jpn J Ophthalmol
Nakagawa Y, Murayama Y, Suzuki Y, Uchiyama A, Suzuki T.   +4 more
europepmc   +1 more source

Off-label use of Avastin in Pakistan: Lessons from the 2023 Punjab outbreak. [PDF]

J Public Health Res
Ali SM, Iqbal A, Hamid Z, Rauf SA, Haque MA.   +4 more
europepmc   +1 more source

Laser Photocoagulation Subsequent to Intravitreal Ranibizumab for Retinopathy of Prematurity Long-Term Efficacy in Extremely Low Birth Weight Twins. [PDF]

J Ophthalmol
Chen JG, Hong X, Huang QQ, Mo KX, Zhang JJ.   +4 more
europepmc   +1 more source

Anti-VEGFs for Diabetic Macular Oedema: Analysis of Efficacy, Safety, and Cost of More Durable Therapies from a Dutch Societal Perspective. [PDF]

Adv Ther
Quist SW, Paulissen JHJ, Lunk I, Carrasco J, Woudstra MA, Pochopien M, Nikodem M, Crossan C, Amarakoon S, van Asten F, Postma MJ.   +10 more
europepmc   +1 more source

Global trends in retinal vein occlusion studies from 2004 to 2023: a bibliometric analysis. [PDF]

Int J Ophthalmol
Sun MS, Cui HP, Tang JC.
europepmc   +1 more source

Recent advancements in polymer science for retinal diseases: New frontiers in drug delivery systems. [PDF]

APL Bioeng
Wang W, Wang N, Zhao X, Su X, Liu Z.
europepmc   +1 more source

Association of serum proinflammatory factors with clinical response to ranibizumab for diabetic macular edema. [PDF]

Exp Ther Med
Gao X, Li H, Diao J, Liu D, Sun W, Zhou Z.   +5 more
europepmc   +1 more source

Sozinibercept (Anti-VEGF-C/-D) Combined with Ranibizumab for Polypoidal Choroidal Vasculopathy: Phase IIb Predefined Subgroup Analysis. [PDF]

Ophthalmol Sci
Cheung CMG, Jackson TL, Wykoff CC, Khanani AM, Leitch IM, Baldwin ME, Slakter J.   +6 more
europepmc   +1 more source